FGFR3 and neoplasm: Considering its inverse relationship with anti-tumor immune response and the relationship to the phenotype of lymphocyte exclusion (Sweis et al., 2016), it is a reasonable to expect MHC-L tumors with low immune infiltration to be enriched by FGFR3 gene mutations.